Skip to main content

Posts

Showing posts from March, 2020

CANDIFORCE-200: Composition, Description, Pharmacological Action, Precaution, Adverse Effects, Dosage, Storage, Uses

                  CANDIFORCE - 200                     Itraconazole Capsules BP           ______________________________________ COMPOSITION : Each HPMC capsule contains  Itraconazole BP                200 mg Excipients q.s. Approved colors used in the capsule shells. (Carmoisine, Ponceau-4R & Titanium Dioxide IP) DESCRIPTION:     Itraconazole is a synthetic triazole antifungal agent. Itraconazole is indicated for the treatment of the fungal infections in immunocompromised and non-immunocompromised patients. PHARMACOLOGICAL ACTION: 1.PHARMACODYNAMIC / MECHANISM OF ACTION :           In vitro studies have demonstrated that itraconazole inhibits the cytochrome P450-dependent synthesis of ergosterol, which is a vital component of fungal cell membranes.  2.PHARMACOKINETICS  : A.ABSORPTION & PLASMA LEVELS -                     Itraconazole is absorbed from the gastrointestinal tract when given orally either as capsules containing it

COVID-19

                       COVID-19       (CORONAVIRUS DISEASE 2019) DESCRIPTION:       Coronavirus disease is an infectious disease like flu disease. The incubation period of this disease is 14days which time does not develop any symptoms. Most people about 80% recover from the disease without needing special treatment. More rarely, the disease can be serious and even fatal older people, children and people having a medical condition such as ASTHMA, DIABETES, HEART DISEASE, CHRONIC RESPIRATORY DISEASE, CANCER. SYMPTOMS :  The symptoms may appear 2-14days after exposure(based on the incubation period of MERS - CoV viruses);                        (a) Fever                (b) Cough                (c) Shortness of breath Seek medical advice if you develop symptoms;                (a) Trouble breathing                (b) Persistent pain or pressure in the chest                (c) New confusion or inability to arouse            
                  UNWANTED - KIT COMPOSITION: Each kit contains,     (A) One Mifepristone Tablets IP             Mifepristone IP.       200mg    (B)Four Misoprostol Tablets IP             Misoprostol IP.        200mcg DOSAGE FORM:      For oral use- Mifepristone tablets      For vaginal use- Misoprostol tablets DESCRIPTION:           The unwanted kit is a combi pack of 1 tablet of Mifepristone 200mg and 4 tablets of Misoprostol 200mcg. Mifepristone tablet is to be administered orally and Misoprostol is to be given vaginally for the medical termination of pregnancy up to 9 weeks. This kit has been developed in accordance with guidelines issued by the Royal College of Obstetricians and Gynecologists, UK. Mifepristone exhibits anti-progestational activity i.e by inhibiting the activity of progesterone, mifepristone results in termination of pregnancy. Mifepristone also shows anti -glucocorticoid and weak anti-androgenic activity. Misoprostol is synthetic prostaglandin E1 ana

D.Pharm -II Examination-2009(I), Pharmaceutics-II Questions, Odisha State Board Pharmacy

  ___________________________________    ODISHA STATE BOARD OF PHARMACY            D.Pharm -II Examination-2009(I)                         Pharmaceutics-II                  (Answer any five questions including question no. -1) Time - 3 hours.                          Full Marks - 80 ____________________________________ 1.     (a) Define the following with examples:                                                                               (4x2           (I) Inhalations           (I) Throat points         (III) Elixirs         (IV) Disinfectants     (b) Gives English meaning of the following:                                                      (1x8            (I) a.c.     (II) t.i.w.    (III) h.s           (IV) P.C.   (V) q.i.d.    (VI) noct           (VII) q.d. (VIII) u.d 2.     (a) Define parenteral products. Describe elaborately facilities required for the production of parenteral products.                                                                     

Tazomac-composition, description, pharmacological action, adverse effects, dosage, storage, alternative brands, images, precaution

                           Tazomac        Piperacillin and Tazobactam             Injection IP COMPOSITION:   Tazomac 2.25gm   Each vial contain;   Piperacillin sodium.                          2.0gm   Tazobactam sodium.                       0.25gm   Tazomac 4.5gm    Each vial contain;    Piperacillin sodium.                          4.0gm      Tazobactam sodium.                         0.5gm   DESCRIPTION:       Piperacillin-Tazobactam is an injectable antibacterial combination product consisting of the semisynthetic antibiotic piperacillin sodium and the beta-lactamase inhibitor Tazobactam sodium for intravenous administration. Piperacillin sodium exerts bactericidal activity by inhibiting septum formation and cell wall synthesis of susceptible bacteria. In vitro, piperacillin is active against a variety of gram-positive and gram-negative aerobic and anaerobic bacteria. Tazobactam sodium has little clinically relevant in vitro activity against bact